These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 7511933)

  • 1. ApoE-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum.
    Palinski W; Ord VA; Plump AS; Breslow JL; Steinberg D; Witztum JL
    Arterioscler Thromb; 1994 Apr; 14(4):605-16. PubMed ID: 7511933
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma.
    Palinski W; Hörkkö S; Miller E; Steinbrecher UP; Powell HC; Curtiss LK; Witztum JL
    J Clin Invest; 1996 Aug; 98(3):800-14. PubMed ID: 8698873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low density lipoprotein undergoes oxidative modification in vivo.
    Palinski W; Rosenfeld ME; Ylä-Herttuala S; Gurtner GC; Socher SS; Butler SW; Parthasarathy S; Carew TE; Steinberg D; Witztum JL
    Proc Natl Acad Sci U S A; 1989 Feb; 86(4):1372-6. PubMed ID: 2465552
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iron-deficient diet reduces atherosclerotic lesions in apoE-deficient mice.
    Lee TS; Shiao MS; Pan CC; Chau LY
    Circulation; 1999 Mar; 99(9):1222-9. PubMed ID: 10069791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis.
    Palinski W; Miller E; Witztum JL
    Proc Natl Acad Sci U S A; 1995 Jan; 92(3):821-5. PubMed ID: 7846059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunization of LDL receptor-deficient mice with homologous malondialdehyde-modified and native LDL reduces progression of atherosclerosis by mechanisms other than induction of high titers of antibodies to oxidative neoepitopes.
    Freigang S; Hörkkö S; Miller E; Witztum JL; Palinski W
    Arterioscler Thromb Vasc Biol; 1998 Dec; 18(12):1972-82. PubMed ID: 9848892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human-derived anti-oxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to atherosclerotic lesions in vivo.
    Shaw PX; Hörkkö S; Tsimikas S; Chang MK; Palinski W; Silverman GJ; Chen PP; Witztum JL
    Arterioscler Thromb Vasc Biol; 2001 Aug; 21(8):1333-9. PubMed ID: 11498462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of atherosclerotic lesions in apo E3-leiden transgenic mice.
    Leppänen P; Luoma JS; Hofker MH; Havekes LM; Ylä-Herttuala S
    Atherosclerosis; 1998 Jan; 136(1):147-52. PubMed ID: 9544741
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein.
    Palinski W; Ylä-Herttuala S; Rosenfeld ME; Butler SW; Socher SA; Parthasarathy S; Curtiss LK; Witztum JL
    Arteriosclerosis; 1990; 10(3):325-35. PubMed ID: 1693068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL.
    Ylä-Herttuala S; Palinski W; Butler SW; Picard S; Steinberg D; Witztum JL
    Arterioscler Thromb; 1994 Jan; 14(1):32-40. PubMed ID: 7506053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the antioxidant N,N'-diphenyl 1,4-phenylenediamine (DPPD) on atherosclerosis in apoE-deficient mice.
    Tangirala RK; Casanada F; Miller E; Witztum JL; Steinberg D; Palinski W
    Arterioscler Thromb Vasc Biol; 1995 Oct; 15(10):1625-30. PubMed ID: 7583536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo.
    Tsimikas S; Palinski W; Halpern SE; Yeung DW; Curtiss LK; Witztum JL
    J Nucl Cardiol; 1999; 6(1 Pt 1):41-53. PubMed ID: 10070840
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo uptake of radiolabeled MDA2, an oxidation-specific monoclonal antibody, provides an accurate measure of atherosclerotic lesions rich in oxidized LDL and is highly sensitive to their regression.
    Tsimikas S; Shortal BP; Witztum JL; Palinski W
    Arterioscler Thromb Vasc Biol; 2000 Mar; 20(3):689-97. PubMed ID: 10712392
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of 12/15-lipoxygenase expression decreases lipid peroxidation and atherogenesis in apolipoprotein e-deficient mice.
    Cyrus T; Praticò D; Zhao L; Witztum JL; Rader DJ; Rokach J; FitzGerald GA; Funk CD
    Circulation; 2001 May; 103(18):2277-82. PubMed ID: 11342477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating autoantibodies to oxidized LDL correlate with arterial accumulation and depletion of oxidized LDL in LDL receptor-deficient mice.
    Tsimikas S; Palinski W; Witztum JL
    Arterioscler Thromb Vasc Biol; 2001 Jan; 21(1):95-100. PubMed ID: 11145939
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-density lipoproteins retard the progression of atherosclerosis and favorably remodel lesions without suppressing indices of inflammation or oxidation.
    Choudhury RP; Rong JX; Trogan E; Elmalem VI; Dansky HM; Breslow JL; Witztum JL; Fallon JT; Fisher EA
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1904-9. PubMed ID: 15319266
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dietary beta-carotene and alpha-tocopherol combination does not inhibit atherogenesis in an ApoE-deficient mouse model.
    Shaish A; George J; Gilburd B; Keren P; Levkovitz H; Harats D
    Arterioscler Thromb Vasc Biol; 1999 Jun; 19(6):1470-5. PubMed ID: 10364077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of atherosclerosis in murine models: correlation between lesions in the aortic origin and in the entire aorta, and differences in the extent of lesions between sexes in LDL receptor-deficient and apolipoprotein E-deficient mice.
    Tangirala RK; Rubin EM; Palinski W
    J Lipid Res; 1995 Nov; 36(11):2320-8. PubMed ID: 8656070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low density lipoprotein oxidation and atherogenesis: from experimental models to clinical studies.
    Napoli C
    G Ital Cardiol; 1997 Dec; 27(12):1302-14. PubMed ID: 9470066
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis.
    Mertens A; Verhamme P; Bielicki JK; Phillips MC; Quarck R; Verreth W; Stengel D; Ninio E; Navab M; Mackness B; Mackness M; Holvoet P
    Circulation; 2003 Apr; 107(12):1640-6. PubMed ID: 12668499
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.